semaglutide sublingual drops for weight loss 10-Week Program (5 mg Vial) Semaglutide 5 mg

But what exactly is semaglutide compounding, and what should patients and providers know about it

SURMOUNT-1 and STEP-1: Obesity-Specific Trials SURMOUNT-1 (Tirzepatide for Obesity, NEJM 2022): At the maximum 15 mg dose, participants without diabetes lost an average of 22.5% of their body weight over 72 weeks approximately 51 lbs for a 225-lb person

Three of the trials included both placebo and active control groups, while others were either placebo- or active-controlled

The 28.7% average weight loss observed in TRIUMPH 4 places this medication in a category of its own, which should strengthen the case for expedited review

Together, we can make sustainable weight loss attainable and tailored to your individual needs